203 related articles for article (PubMed ID: 7204076)
21. Treatment and prognosis of gastric lymphoma.
Brands F; Mönig SP; Raab M
Eur J Surg; 1997 Nov; 163(11):803-13. PubMed ID: 9414040
[TBL] [Abstract][Full Text] [Related]
22. [Gastric non-Hodgkin lymphoma: guidelines for the therapeutic approach].
Bellini M; Salvatore G; Di Palma R; Cataneo M; Pede A; De Martino C
Chir Ital; 2003; 55(3):391-7. PubMed ID: 12872575
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal lymphoma: a surgical perspective.
Thirlby RC
Oncology (Williston Park); 1993 Jan; 7(1):29-32, 34; discussion 34, 37-8. PubMed ID: 8420540
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
25. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576
[TBL] [Abstract][Full Text] [Related]
26. The surgeon's attitude to malignant lymphomas of the breast. Analysis of eight cases.
Salvadori B; Cusumano F; De Lellis R
Eur J Surg Oncol; 1986 Mar; 12(1):47-51. PubMed ID: 3956754
[TBL] [Abstract][Full Text] [Related]
27. Lymphomas of the gastrointestinal tract.
Mcgovern VJ
Monogr Pathol; 1977; (18):184-205. PubMed ID: 611413
[TBL] [Abstract][Full Text] [Related]
28. [Primary gastrointestinal lymphomas: response to eradicative therapy and prognostic factors in 52 patients].
Hernández JA; Ribera JM; Oriol A; Batlle M; Vaquero M; Flores A; Fernández-Llamazares J; Piñol M; Millá F; Feliu E
Med Clin (Barc); 1998 Jan; 110(2):45-50. PubMed ID: 9580161
[TBL] [Abstract][Full Text] [Related]
29. A retrospective analysis of the clinical results in relation to the Rappaport histological classification.
Brown TC; Peters MV; Bergsagel DE; Reid J
Br J Cancer Suppl; 1975 Mar; 2():174-86. PubMed ID: 1182069
[TBL] [Abstract][Full Text] [Related]
30. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D deficiency in patients operated on for gastric lymphoma.
Hollender A; Bjøro T; Otto Karlsen K; Kvaloy SO; Nome O; Holte H
Scand J Gastroenterol; 2006 Jun; 41(6):673-81. PubMed ID: 16716965
[TBL] [Abstract][Full Text] [Related]
32. Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study.
Kolokotronis A; Konstantinou N; Christakis I; Papadimitriou P; Matiakis A; Zaraboukas T; Antoniades D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):303-10. PubMed ID: 15716836
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of conservative treatment of gastric lymphosarcoma].
Zvonkov EE; Kremenetskaia AM; Kravchenko SK; Makhinia VA; Kaplanskaia IB; Obukhova TN; Samoĭlova RS; Shevelev AA; Magomedova AU; Bariakh EA; Krasil'nikova BB; Gubkin AV; Iliushkina EA; Mar'in DS; Morozova AK; Kulikov SM; Gemdzhian EG; Vorob'ev AI
Ter Arkh; 2008; 80(7):18-26. PubMed ID: 18763589
[TBL] [Abstract][Full Text] [Related]
34. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
35. [Multivariate analysis of prognosis of patients with stage IE non-Hodgkin's lymphomas of the nasal cavity].
Hu W; Chen M; Luo F
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):240-3. PubMed ID: 11783097
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
37. Primary non-Hodgkin lymphoma of the stomach--role of surgery.
Steinau G; Riesener KP; Schleef J; Steinau B; Schumpelick V
Hepatogastroenterology; 1997; 44(17):1513-8. PubMed ID: 9356882
[TBL] [Abstract][Full Text] [Related]
38. Labeling index as a prognostic marker in non-Hodgkin's lymphomas.
Costa A; Bonadonna G; Villa E; Valagussa P; Silvestrini R
J Natl Cancer Inst; 1981 Jan; 66(1):1-5. PubMed ID: 6935451
[TBL] [Abstract][Full Text] [Related]
39. Complete remission by chemotherapy in stage IE-IIE primary gastric lymphoma.
Kochi M; Fujii M; Kanamori N; Kaiga T; Takahashi T; Kobayashi M; Takayama T
Hepatogastroenterology; 2007 Jun; 54(76):1285-8. PubMed ID: 17629090
[TBL] [Abstract][Full Text] [Related]
40. Primary gastric lymphoma and pseudolymphoma.
Jung SS; Wieman TJ; Lindberg RD
Am Surg; 1988 Oct; 54(10):594-7. PubMed ID: 3178044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
